Glassman Wealth Services Pa Vmed Inc. Transaction History

Glassman Wealth Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.22 - $0.5 $7,651 - $17,389	34,779 New	34,779 $10,000
Q1 2022 Aug 23, 2022	BUY	$1.16 - $2.5 $40,343 - $86,947	34,779 New	34,779 $46,000
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $51,116 - $181,608	-20,779 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$3.95 - $6.88 $7,900 - $13,760	2,000 Added 10.65%	20,779 $133,000
Q4 2020 Feb 04, 2021	SELL	$1.73 - $2.13 $56,865 - $70,013	-32,870 Reduced 63.64%	18,779 $40,000
Q1 2020 May 12, 2020	BUY	$1.15 - $3.29 $21,275 - $60,865	18,500 Added 55.81%	51,649 $102,000
Q4 2019 Feb 07, 2020	BUY	$0.84 - $1.2 $840 - $1,200	1,000 Added 3.11%	33,149 $40,000
Q3 2019 Nov 01, 2019	BUY	$0.95 - $1.11 $10,830 - $12,654	11,400 Added 54.94%	32,149 $31,000
Q2 2019 Aug 08, 2019	BUY	$1.03 - $1.32 $13,441 - $17,226	13,050 Added 169.5%	20,749 $24,000
Q4 2018 Feb 06, 2019	BUY	$0.92 - $1.31 $7,083 - $10,085	7,699 New	7,699 $7,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $92.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.